Washington, D.C. · Nonprofit
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC (Washington, D.C.) receives grants from 2 organizations whose IRS filings report $23,175 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($23,150). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2021
- $320k
- Funders on record
- 2
- Grants received
- $23k
- Net assets
- $0
What Melanoma Research Foundation Breakthrough Consortium Inc does
Mission
The mission of the melanoma research foundation breakthrough consortium, inc. (the consortium) is to accelerate the research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients. The consortium will develop collaborative, multi-sector partnerships across the breadth of melanoma disciplines - basic, translational and clinical science - to expedite development of combinations of therapies as well as novel single agents; support pre-clinical research to facilitate rational combinations; create a virtual annotated specimen biorepository; and identify biomarkers that have prognostic and predictive value or value as a new therapeutic target.
As stated on its FY2021 Form 990.
Program
The consortium seeks to accelerate research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients. Success in this endeavor also furthers the exempt purpose of the melanoma research foundation (mrf). In order to achieve its mission, the consortium will develop collaborative, multi-sector partnerships across the breadth of melanoma disciplines- basic, translational and clinical science- to expedite development of combination therapies as well as novel single agents; support preclinical research to facilitate rational combinations; create a virtual annotated specimen biorepository; and identify biomarkers that have prognostic and predictive value or value as new therapeutic targets which required the expertise of a md and project manager. In addition, the consortium's board of directors and participating research institutions will conduct outreach to multi sector partners with an interest or investment in melanoma research to ensure that the consortium is aware of any important developments or promising research in the field of melanoma.
The first program described on its most recent Form 990, which lists programs largest first by expense.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $558k to $0 (−100%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2022: the base held at 1 funder, grant income rose $6k → $17k.
1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $290k from one payer (the payer shares this organization's board, largest Melanoma Research Foundation). These are real filings, and they are not money MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC raised.
From the IRS filings of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC leans on a few funders — its largest provides 100% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC.
Largest funder’s share by year: 2017 100% · 2021 100% · 2022 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $25 that is directly attributable, 100% of it comes from funders outside Washington, D.C., across 1 state.
Funder states come from each funder’s own filing. $23k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington, D.C.
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
99% of spending goes to programs.
Governance
Footprint & structure
Part of a family of 1 related entity
- Melanoma Research Foundation · exempt
Screen this organization
A dated, signed PDF of the compliance screen for MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC?
- MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC (Washington, D.C.) receives grants from 2 organizations whose IRS filings report $23,175 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($23,150). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC have?
- IRS filings report 2 organizations giving $23,175 in grants to MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC, 1 of which have funded it in more than one year.
- Who is the largest funder of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $23,150 in grants. The full list of funders is on this page.
- How can an organization like MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington, D.C.. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2021 (financials across 2017–2021), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing